Curebase Series B
4 known investors
Curebase provides technology infrastructure for clinical trial sites, offering tools to help research centers manage and conduct trials more efficiently. The platform serves contract research organizations and trial sponsors conducting clinical studies.
Investors · 4
In the news
- Curebase is decentralizing clinical trials with $40m roundtechcrunch.com · 2022
- Curebase Secures $40 Million in Series B Fundingprnewswire.com · 2022
- Curebase - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Curebase Inks $15M Series A For New Approach To Clinical Trialsnews.crunchbase.com · 2021
- Curebase Raises $15M in Series A Funding - FinSMEsfinsmes.com · 2021
- Curebase Unlocks Drug Development With Remote Clinical Trials; Raises $15M Led By GGV Capitalprnewswire.com · 2021